• <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
      <b id="1ykh9"><small id="1ykh9"></small></b>
    1. <b id="1ykh9"></b>

      1. <button id="1ykh9"></button>
        <video id="1ykh9"></video>
      2. west china medical publishers
        Author
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Author "吉冰洋" 15 results
        • 中深度低溫選擇性腦灌注在DeBakey-I型夾層動脈瘤術中的應用

          目的為了減少DeBakey-Ⅰ型夾層動脈瘤患者術后神經系統及其他系統并發癥, 探討其灌注方法. 方法 20例 DeBakey-Ⅰ型動脈瘤患者均采用中深度低溫停循環選擇性腦灌注和下半身灌注技術行象鼻手術. 結果全組患者無死亡,1例由于病變壓迫髂總動脈而致術后發生第4胸椎以下軟癱,1例術后發生急性腎功能衰竭,其余患者無任何術后并發癥,痊愈出院. 結論中深度低溫停循環選擇性腦灌注和下半身灌注技術可以延長大腦和脊髓的安全保護時限,減少術后并發癥,并有效地配合完成手術,提高手術療效.

          Release date:2016-08-30 06:30 Export PDF Favorites Scan
        • Research progress on deep hypothermic circulatory arrest in rat model

          Deep hypothermic circulatory arrest (DHCA) technology is the basic means of organ protection in complex aortic arch surgeries, congenital heart disease surgeries, pulmonary endarterectomy and other operations. The establishment of DHCA in rat model is helpful to explore the influence of DHCA and its pathophysiological pathways. However, there are some problems in this process, such as imperfect monitoring, inaccurate management and non-standard heparinization during the experimental period. It is necessary to review relevant literatures on DHCA rat model, in order to establish a DHCA rat model with standardized operation, clear standards and mature technology.

          Release date:2022-12-28 06:02 Export PDF Favorites Scan
        • 體外循環中烏司他丁對機體的保護作用

          烏司他丁(尿胰蛋白酶抑制劑)是由143個氨基酸組成,分子量為66 464u的酸性蛋白質,其凍干品為白色或淡褐色塊狀物或粉末;是從健康男性尿中分離純化的糖蛋白,它有多種特殊的藥理性質,為一種廣譜酶抑制劑,對多種酶、糖和脂水解酶有抑制作用.在體外循環過程中由于機體處于一種非生理狀態下,同時伴有缺血、缺氧和各種酶、炎性介質、自由基的大量釋放,導致機體心臟、肺、腎等重要器官和血管內皮損傷.烏司他丁作為一種蛋白酶抑制劑能較為有效的競爭性或非競爭性抑制由體外循環非生理作用引發的一系列酶以及炎性介質的釋放,同時起到保護機體重要器官的作用.

          Release date:2016-08-30 06:31 Export PDF Favorites Scan
        • DeBakeyⅢ型主動脈夾層外科治療的體外循環管理

          目的 探討DeBakeyⅢ型主動脈夾層外科治療的體外循環管理方法,以減少術后并發癥的發生。方法 22例急、慢性DeBakeyⅢ型主動脈夾層患者行外科治療,其中6例應用常溫股(髂)動脈-股靜脈轉流方法行動脈瘤切除和人工血管置換,11例采用深低溫停循環下行部分胸主動脈、全部胸主動脈或胸腹主動脈人工血管置換,5例采用血泵法全血回收+股動脈輸入技術行人工血管置換。結果 常溫股動脈0股靜脈轉流患者體外循環轉流時間30.8±6.1min,庫血用量560±120ml;深低溫停循環患者最低鼻咽溫15~18℃,體外循環時間168.5±47.3min,庫血用量1028±350ml;血液回收+股動脈輸入患者無1例輸入庫血。全組患者氣管內插管時間17.4±4.8h,ICU停留時間2.9±1.8d;住院期間無死亡,無重要器官并發癥發生。結論 針對DeBakeyⅢ型主動脈夾層的外科治療,合理采用不同的體外循環管理方法,可有效地減少術后的病死率和并發癥發生率。

          Release date:2016-08-30 06:26 Export PDF Favorites Scan
        • 急癥體外循環

          目的回顧最近2年急診體外循環病例,分析其特點并總結經驗. 方法收集1998~1999年間共97例急診體外循環心血管手術臨床資料,其中動脈瘤20例,冠狀動脈旁路移植術15例,粘液瘤17例,心瓣膜置換術16例,先天性心臟病急性缺氧發作18例,大血管破裂出血6例,心室輔助3例,主動脈竇瘤破裂2例,涉及多種體外循環方法的應用. 結果早期主要并發癥為低心排血量、出血、短時間的神經系統功能障礙,共20例,占20.6%;死亡8例,占8.2%;其余患者順利出院,目前正接受長期隨訪. 結論 急診體外循環在心血管急診手術中非常重要,快速建立體外循環,針對不同病情采取相應措施是手術成功和減少并發癥的關鍵。

          Release date:2016-08-30 06:34 Export PDF Favorites Scan
        • 深低溫下肺動脈取栓術的體外循環管理

          目的 總結在深低溫下行肺動脈取栓術體外循環管理的經驗。方法 7例急性肺栓塞患者均在深低溫低流量和深低溫停循環下行肺動脈取栓術,并通過間斷恢復血流,延遲復溫,藥物處理等技術,保護患者的心、腦、肺、腎等功能。結果 1例由于體外循環時間較長(335分鐘),且心功能較差,靜脈血氧飽和度不能有效的維持,脫機困難,使用了體外膜肺支持,最終因多器官功能衰竭而死亡。1例因肺水腫施行二次肺動脈環縮術后,肺水腫明顯改善;其他患者術后恢復順利。結論 在深低溫體外循環下行肺動脈取栓術是安全有效的方法。

          Release date:2016-08-30 06:33 Export PDF Favorites Scan
        • Research advances on extracorporeal membrane oxygenation in rat model

          Extracorporeal membrane oxygenation (ECMO) is a critical life support technique for patients with severe cardiopulmonary failure. Establishing a stable ECMO animal model is essential to further investigate the effects of ECMO on the body and provide assistance for optimizing ECMO management strategies and preventing complications in clinical practice. In recent years, rats have been widely used to establish ECMO models due to their low cost and good reproducibility. Therefore, this article provided a comprehensive review of literature on the ECMO rat model, including equipment and experimental management strategies. It offers a theoretical foundation for the development of a stable and mature ECMO rat model in the future.

          Release date:2024-05-28 03:37 Export PDF Favorites Scan
        • Evaluation of Shunting Flow Differences in Varied Conditions in a Simulated Adult Cardiopulmonary Bypass Model

          Abstract: Objective To evaluate different shunting flow in varied conditions in a simulated adult cardiopulmonary bypass (CPB) model under normothermia. Methods We established the pseudo adult patient undergoing CPB at four different shunting states with devices of heartlung machine, heatcooler, an adult membrane oxygenator and arterial filter. In state 1, purge line of the arterial filter was open alone; In state 2, purge line combined with 6.5 mm tubing hemoconcentrator shunting was open; In state 3, purge line combined with 5 mm tubing hemoconcentrator was open; In state 4, purge line combined with blood cardioplegia shunting was open. The flow of preoxygenator and postfilter was recorded with ultrasonic flowmeter, and the pressure of purge line and postarterial filter was also detected. Results At state 1, when the pump flow was invariable, the percentage of the shunting flow increased with the increase of postfilter pressure. However, when the postfilter pressure was constant, the percentage of the shunting flow decreased with the increase of the pump flow. The purge line pressure increased with the increase of the postfilter pressure at a constant pump flow under state 1. The shunting flow of state 2 was the largest among all the four states. The shunting flow of state 3 was similar to that of state 4. All the purge line pressure was lower than the postfiler pressure of the circuit in the four states. Conclusion Under states of different shunting opening, different degrees of blood flow are diverted away from the arterial line. The shunting flow increases at a lower pump flow and a higher postfilter pressure. A flow probe located in the postfilter line may be necessary to monitor realtime arterial flow.

          Release date: Export PDF Favorites Scan
        • Guidelines on patient blood management for adult cardiovascular surgery under cardiopulmonary bypass

          Working Group on Extracorporeal Life Support, National Center for Cardiovascular Quality Improvement developed guidelines on patient blood management for adult cardiovascular surgery under cardiopulmonary bypass, aiming to standardize patient blood management in adult cardiovascular surgery under cardiopulmonary bypass, reduce blood resource consumption, and improve patients outcomes. Forty-eight domestic experts participated in the development of the guidelines. Based on prior investigation and the PICO (patient, intervention, control, outcome) principles, thirteen clinical questions from four aspects were selected, including priming and fluid management during cardiopulmonary bypass, anticoagulation and monitoring during cardiopulmonary bypass, peri-cardiopulmonary bypass blood product infusion, and autologous blood infusion. Systemic reviews to the thirteen questions were performed through literature search. Recommendations were drafted using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. After five rounds of experts discussions between 2023 and 2024, 19 recommendations were finally formed.

          Release date:2024-11-27 02:45 Export PDF Favorites Scan
        • Expression of MicroRNA-1, 21 in Ischemic Preconditioning, Ischemic Postconditioning and Remote Ischemic Preconditioning in an Isolated Rat Heart Model

          Abstract: Objective To observe the expression changes of microRNA 1 (miRNA-1) and microRNA 21(miRNA-21) after ischemic preconditioning (IPC), ischemic postconditioning (IPO) and remote ischemic preconditioning (RIPC)in an ischemia-reperfusion rat heart model in vitro, as well as the expression of their target protein heat shock protein 70 (HSP70) and programmed cell death 4 (PDCD4), and evaluate whether miRNA are involved in endogenous cardio-protective mechanism. Methods The Langendorff-perfused Sprague-Dawley rat hearts were randomly assigned into one of the four groups, control group (CON group, n=12), ischemia preconditioning group (IPC group, n=12)?, ischemia postconditioning group (IPO group, n=12) and remote ischemia preconditioning group (RIPC group,n=12). Cardiac function was digitalized and analyzed. The expression of HSP70, PDCD4, B-cell lymphoma/leukemia-2 (Bcl-2) and Bax was detected by Western blotting. The expression of miRNA-1 and miRNA-21 was detected by real-time reverse transcriotion-polymerase chain reaction (RT-PCR). Assessment of cardiac infarct size and myocardial apoptosis was determined using triphenyltetrazolium chloride (TTC) assay and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay (TUNEL) assay respectively. Results The expressions of miRNA-1 and miRNA-21 were up-regulated in IPC group, but the expression of miRNA-1 was down-regulated in RIPC group and IPO group (P<0.05). The expressionsof PDCD4, HSP70 and Bax were down-regulated in ‘conditioning’ groups compared with CON group (P<0.05). The expression of Bcl-2 was not statistically different among the four groups. The infarct size and the myocardial apoptosis in ‘conditioning’ hearts were significantly decreased compared with CON group (P<0.05). Conclusion The expressions of the miRNA-1 and miRNA-21 are different in IPC, RIPC and IPO groups, and their target proteins are not inversely correlated with the miRNAs in all the ‘conditioning’ groups.

          Release date:2016-08-30 05:50 Export PDF Favorites Scan
        2 pages Previous 1 2 Next

        Format

        Content

      3. <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
          <b id="1ykh9"><small id="1ykh9"></small></b>
        1. <b id="1ykh9"></b>

          1. <button id="1ykh9"></button>
            <video id="1ykh9"></video>
          2. 射丝袜